These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19585953)

  • 1. Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?
    Brickman AM; Muraskin J; Zimmerman ME
    Dialogues Clin Neurosci; 2009; 11(2):181-90. PubMed ID: 19585953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
    Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
    Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
    Makedonov I; Black SE; MacIntosh BJ
    Eur J Neurol; 2013 Feb; 20(2):243-50. PubMed ID: 22742818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
    Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
    JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
    Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
    Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter predictors of cognitive functioning in older adults.
    Meier IB; Manly JJ; Provenzano FA; Louie KS; Wasserman BT; Griffith EY; Hector JT; Allocco E; Brickman AM
    J Int Neuropsychol Soc; 2012 May; 18(3):414-27. PubMed ID: 22390883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study.
    Gao FQ; Swartz RH; Scheltens P; Leibovitch FS; Kiss A; Honjo K; Black SE
    J Alzheimers Dis; 2011; 26 Suppl 3():379-88. PubMed ID: 21971477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
    Carmichael O; Schwarz C; Drucker D; Fletcher E; Harvey D; Beckett L; Jack CR; Weiner M; DeCarli C;
    Arch Neurol; 2010 Nov; 67(11):1370-8. PubMed ID: 21060014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
    Brickman AM
    Curr Neurol Neurosci Rep; 2013 Dec; 13(12):415. PubMed ID: 24190781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease.
    Brickman AM; Honig LS; Scarmeas N; Tatarina O; Sanders L; Albert MS; Brandt J; Blacker D; Stern Y
    Arch Neurol; 2008 Sep; 65(9):1202-8. PubMed ID: 18779424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study.
    Ramirez J; McNeely AA; Scott CJM; Masellis M; Black SE;
    Alzheimers Dement; 2016 Feb; 12(2):203-210. PubMed ID: 26208292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities and cognition: testing the reserve hypothesis.
    Brickman AM; Siedlecki KL; Muraskin J; Manly JJ; Luchsinger JA; Yeung LK; Brown TR; DeCarli C; Stern Y
    Neurobiol Aging; 2011 Sep; 32(9):1588-98. PubMed ID: 19926168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.
    Birdsill AC; Koscik RL; Jonaitis EM; Johnson SC; Okonkwo OC; Hermann BP; Larue A; Sager MA; Bendlin BB
    Neurobiol Aging; 2014 Apr; 35(4):769-76. PubMed ID: 24199958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.
    Ithapu V; Singh V; Lindner C; Austin BP; Hinrichs C; Carlsson CM; Bendlin BB; Johnson SC
    Hum Brain Mapp; 2014 Aug; 35(8):4219-35. PubMed ID: 24510744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities.
    Nebes RD; Snitz BE; Cohen AD; Aizenstein HJ; Saxton JA; Halligan EM; Mathis CA; Price JC; Kamboh MI; Weissfeld LA; Klunk WE
    Neuropsychologia; 2013 Sep; 51(11):2202-9. PubMed ID: 23911776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.